Jazz Pharmaceuticals
JAZZ
#2002
Rank
โ‚น917.29 B
Marketcap
โ‚น15,096
Share price
0.31%
Change (1 day)
42.99%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚น60.21 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚น4.15 Billion. In 2024 the company made an earning of โ‚น43.16 Billion, an increase over its 2023 earnings that were of โ‚น27.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น60.21 Billion-239.47%
2024 โ‚น43.16 B57.87%
2023 โ‚น27.34 B-179.92%
2022 -โ‚น34.22 Billion230.37%
2021 -โ‚น10.36 Billion-141.02%
2020 โ‚น25.24 B-39.45%
2019 โ‚น41.69 B-14.2%
2018 โ‚น48.59 B20.03%
2017 โ‚น40.48 B-17.15%
2016 โ‚น48.86 B22.14%
2015 โ‚น40.00 B187.64%
2014 โ‚น13.90 B-50.79%
2013 โ‚น28.26 B73.63%
2012 โ‚น16.27 B41.69%
2011 โ‚น11.48 B116.61%
2010 โ‚น5.30 B262.77%
2009 โ‚น1.46 B-111.33%
2008 -โ‚น12.91 Billion1.31%
2007 -โ‚น12.74 Billion77.8%
2006 -โ‚น7.17 Billion36.59%
2005 -โ‚น5.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.506 T-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น192.42 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น219.52 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น162.62 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel